Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
- 1 March 2010
- journal article
- research article
- Published by Elsevier BV in Biological Psychiatry
- Vol. 67 (5), 432-438
- https://doi.org/10.1016/j.biopsych.2009.11.021
Abstract
No abstract availableThis publication has 37 references indexed in Scilit:
- Modulation of cardiac autonomic functions in patients with major depression treated with repetitive transcranial magnetic stimulationJournal of Affective Disorders, 2007
- Selective Effects of Cholinergic Modulation on Task Performance during Selective AttentionNeuropsychopharmacology, 2007
- Antidepressant Efficacy of the Antimuscarinic Drug ScopolamineArchives of General Psychiatry, 2006
- Altered NMDA receptor trafficking contributes to sleep deprivation-induced hippocampal synaptic and cognitive impairmentsBiochemical and Biophysical Research Communications, 2006
- Severity of depressive symptoms and response to antidepressants and placebo in antidepressant trialsJournal of Psychiatric Research, 2005
- Evidence of common and specific genetic effects: association of the muscarinic acetylcholine receptor M2 (CHRM2) gene with alcohol dependence and major depressive syndromeHuman Molecular Genetics, 2004
- Glutamate and DepressionAnnals of the New York Academy of Sciences, 2003
- Association of the muscarinic cholinergic 2 receptor (CHRM2) gene with major depression in womenAmerican Journal of Medical Genetics, 2002
- A Rating Scale for Mania: Reliability, Validity and SensitivityThe British Journal of Psychiatry, 1978
- THE ASSESSMENT OF ANXIETY STATES BY RATINGPsychology and Psychotherapy: Theory, Research and Practice, 1959